Total posterior spine system is a cost-effective option for spondylolisthesis, stenosis

Compared with transforaminal lumbar interbody fusion, the Total Posterior Spine System by Premia Spine is a more cost-effective option for treatment of degenerative lumbar spondylolisthesis and stenosis, according to results.
In a prospective, multicenter, randomized controlled trial, Jared D. Ament, MD, and colleagues analyzed 121 patients (mean age of 64 years) with grade 1 degenerative spondylolisthesis and lumbar stenosis who were randomly assigned to receive either the novel Total Posterior Spine System, also known as TOPS, or standard transforaminal lumbar interbody fusion (TLIF) with a

Compared with transforaminal lumbar interbody fusion, the Total Posterior Spine System by Premia Spine is a more cost-effective option for treatment of degenerative lumbar spondylolisthesis and stenosis, according to results.
In a prospective, multicenter, randomized controlled trial, Jared D. Ament, MD, and colleagues analyzed 121 patients (mean age of 64 years) with grade 1 degenerative spondylolisthesis and lumbar stenosis who were randomly assigned to receive either the novel Total Posterior Spine System, also known as TOPS, or standard transforaminal lumbar interbody fusion (TLIF) with a